Acta Med. 2020, 63: 164-175
https://doi.org/10.14712/18059694.2020.59
Sensitization to Molecular Components in 104 Atopic Dermatitis Patients in Relation to Subgroups of Patients Suffering from Bronchial Asthma and Allergic Rhinitis
References
1. T, Krueger JG, Guttman-Yassky E. Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march. J Allergy Clin Immunol 2017; 139(6): 1723–34.
<https://doi.org/10.1016/j.jaci.2017.04.004>
2. AS, Spergel JM, Mina-Osorio P, Irvine AD. The atopic march and atopic multimorbidity: Many trajectories, many pathways. J Allergy Clin Immunol 2019; 143(1): 46–55.
<https://doi.org/10.1016/j.jaci.2018.11.006>
3. TH, Zhu TR, Tran KA, Sivamani RK, Shi VY. Epithelial barrier dysfunctions in atopic dermatitis: a skin–gut–lung model linking microbiome alteration and immune dysregulation. Br J Dermatol 2018; 179(3): 570–81.
<https://doi.org/10.1111/bjd.16734>
4. Krejsek J, Andrýs C, Krčmová I. Imunologie člověka. In Hradec Králové: Garamon; 2016, p. 213–22.
5. IJ, Melioli G, Walter G, et al. Open Access A WAO–ARIA–GA2LEN consensus document on molecular-based allergy diagnosis (PAMD@): Update 2020. World Allergy Organ J 2020; 13(2): 1–46.
6. T, Yu J, Oh MH, Zhu Z. The atopic march: Progression from atopic dermatitis to allergic rhinitis and asthma. Allergy, Asthma Immunol Res 2011; 3(2): 67–73.
<https://doi.org/10.4168/aair.2011.3.2.67>
<PubMed>
7. Y, Liu X, Huang Y, Zou Z, et al. Reduction of the number of major representative allergens: From clinical testing to 3-dimensional structures. Mediators Inflamm 2014; 2014: 1–11.
8. H, Van Geel MJ, Knulst AC, Huiskes J, Bruijnzeel-Koomen CAFM, De Bruin-Weller MS. Food allergen sensitization pattern in adults in relation to severity of atopic dermatitis. Clin Transl Allergy 2014; 4(1): 1–9.
<https://doi.org/10.1186/2045-7022-4-9>
<PubMed>
9. P, Vachová M, Vítovcová P, Brodská P, Vlas T. A comprehensive analysis of middle-european molecular sensitization profiles to pollen allergens. Int Arch Allergy Immunol 2014; 164(1): 74–82.
<https://doi.org/10.1159/000362760>
10. A, Borres MP, Kober A, Berthold M. Multiplex component- based allergen microarray in recent clinical studies. Clin Exp Allergy 2016; 46(8): 1022–32.
<https://doi.org/10.1111/cea.12761>
11. N, Jordakieva G, Hinterhölzl L, et al. Allergy diagnosis from symptoms to molecules, or from molecules to symptoms: A comparative clinical study. World Allergy Organ J 2018; 11(1): 22.
<https://doi.org/10.1186/s40413-018-0199-y>
<PubMed>
12. G, Melioli G, Bonifazi F, et al. The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy. Allergy Eur J Allergy Clin Immunol 2013; 68(8): 1029–33.
<https://doi.org/10.1111/all.12194>
13. RX, Roberts G, Fox AT, Toit G. Pilot study: Assessing the clinical diagnosis of allergy in atopic children using a microarray assay in addition to skin prick testing and serum specific IgE. Clin Mol Allergy 2016; 14(1): 1–7.
<https://doi.org/10.1186/s12948-016-0046-z>
<PubMed>
14. J, Roh J, Lee J. Clinical Availability of Component-Resolved Diagnosis Using Microarray Technology in Atopic Dermatitis. Ann Dermatol 2014; 26(4): 437–46.
<https://doi.org/10.5021/ad.2014.26.4.437>
<PubMed>
15. M, Hamsten C, Valenta R. ImmunoCAP assays: Pros and cons in allergology. J Allergy Clin Immunol 2017; 140(4): 974–7.
<https://doi.org/10.1016/j.jaci.2017.05.008>
16. G, Bonifazi F, Bonini S, et al. The ImmunoCAP ISAC molecular allergology approach in adult multi-sensitized Italian patients with respiratory symptoms. Clin Biochem 2011; 44(12): 1005–11.
<https://doi.org/10.1016/j.clinbiochem.2011.05.007>
17. M, Żbikowska-Gotz M, Marek-Józefowicz L, Przybyszewski M, Gocki J, Bartuzi Z. Allergic phenotypes in adult patients with atopic dermatitis, determined with the ISAC test (ImmunoCAP ISAC). Postep Dermatologii i Alergol 2018; 35(4): 351–9.
<https://doi.org/10.5114/ada.2018.77664>
<PubMed>
18. H, Fölster-Holst R, Merk HF, Baron JM. Allergen microarrays: A novel tool for high-resolution IgE profiling in adults with atopic dermatitis. Eur J Dermatology 2010; 20(1): 54–61.
19. JM, Rajla G. Diagnostic features of AD. Vol. 92, Acta Dermatovener (Stockholm), 1980, p. 44–7.
20. Severity scoring of atopic dermatitis: the SCORAD Index (Consensus report of the European Task Force on Atopic Dermatitis). Dermatology 1993; 186: 23–31.
21. AP, Glazenburg EJ, Wolkerstorfer A, De Waard-Van Der Spek FB. Practical issues on interpretation of scoring atopic dermatitis: The SCORAD index, objective SCORAD and the three-item severity score. Br J Dermatol 2007; 157(4): 645–8.
<https://doi.org/10.1111/j.1365-2133.2007.08112.x>
22. R, Lizaso MT, Goikoetxea MJ, et al. Is the determination of specific IgE against components using ISAC 112 a reproducible technique? PLoS One 2014; 9(2): 1–7.
<https://doi.org/10.1371/journal.pone.0088394>
<PubMed>
23. T, Forstenlechner P, Matricardi P, Kleine-Tebbe J. Molecular allergy diagnostics using multiplex assays : methodological and practical considerations for use in research and clinical routine. Allergo J Int 2015; 24: 320–32.
<https://doi.org/10.1007/s40629-015-0087-8>
<PubMed>
24. K, Morita K, Narita M, et al. Transepidermal water loss measurement during infancy can predict the subsequent development of atopic dermatitis regardless of filaggrin mutations. Allergol Int 2016; 65(1): 103–8.
<https://doi.org/10.1016/j.alit.2015.09.004>
25. S, Čepelak I. The potential of component-resolved diagnosis in laboratory diagnostics of allergy. Biochem Medica 2018; 28(2): 1–9.
26. JA. Guidelines for the diagnosis and management of food allergy in the United States: Report of the NIAID-sponsored expert panel. J Allergy Clin Immunol 2010; 126(6): 301–402.
<https://doi.org/10.1016/j.jaci.2010.10.008>
<PubMed>
27. A, Werfel T, Hoffmann-Sommergruber K, Roberts G, Beyer K, Bindslev-Jensen C, et al. EAACI Food Allergy and Anaphylaxis Guidelines: Diagnosis and management of food allergy. Allergy Eur J Allergy Clin Immunol 2014; 69(8): 1008–25.
<https://doi.org/10.1111/all.12429>
28. MCF, Belgrave D, Buchan I, Simpson A, Custovic A. Challenges in interpreting allergen microarrays in relation to clinical symptoms: A machine learning approach. Pediatr Allergy Immunol 2014; 25(1): 71–9.
<https://doi.org/10.1111/pai.12139>
<PubMed>
29. L, Panetta V, Lau S, et al. Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J Allergy Clin Immunol 2012; 130(4): 894–901.
<https://doi.org/10.1016/j.jaci.2012.05.053>
30. P, Önell A, Baldracchini F, Hui V, Jolles S, El-Shanawany T. Evaluation of a novel automated allergy microarray platform compared with three other allergy test methods. Clin Exp Immunol 2016; 184(1): 1–10.
<https://doi.org/10.1111/cei.12721>
<PubMed>
31. J, Gutermuth J, Schäffner I, et al. Comparison of molecular and extract-based allergy diagnostics with multiplex and singleplex analysis. Allergo J Int 2015; 24(2): 46–53.
<https://doi.org/10.1007/s40629-015-0046-4>
<PubMed>
32. C, Gutermuth J, Önell A, et al. Comparison of Molecular Multiplex and Singleplex Analysis of IgE to Grass Pollen Allergens in Untreated German Grass Pollen – Allergic Patients. J Investig Allergol Clin Immunol 2015; 25(3): 190–5.
33. JH, Kang G, Kim TS. Comparison of Component-Resolved Diagnosis by Using Allergen Microarray With the Conventional Tests in Allergic Rhinitis Patients : The First Using in Korea. Clin Exp Otorhinolaryngol 2015; 8(4): 385–9.
<https://doi.org/10.3342/ceo.2015.8.4.385>
<PubMed>
34. PM, Hoffmann HJ, Valenta R, et al. EAACI Molecular Allergology User’s Guide. Pediatr Allergy Immunol 2016; 27(23): 1–250.
<https://doi.org/10.1111/pai.12563>
35. P, Vachová M, Vlas T, Vítovcová P, Brodská P, Malý M. Cross-sectional study on sensitization to mite and cockroach allergen components in allergy patients in the Central European region. Clin Transl Allergy 2018; 8(19): 1–9.
<https://doi.org/10.1186/s13601-018-0207-x>
<PubMed>
36. M, Panzner P, Vlas T, Vítovcová P. Analysis of Sensitization Profiles in Central European Allergy Patients Focused on Animal Allergen Molecules. Int Arch Allergy Immunol 2020; 181(4): 278–84.
<https://doi.org/10.1159/000505518>
37. S, Resch Y, Chen KW, et al. Der p 11 is a Major Allergen for House Dust Mite-Allergic Patients Suffering from Atopic Dermatitis. J Invest Dermatol 2015; 135(1): 102–9.
<https://doi.org/10.1038/jid.2014.271>
<PubMed>
38. J, Bukač J, Vaňková R, Krčmová I, Krejsek J, Andrýs C. ISAC multiplex testing – results of examination in 100 patients suffering from atopic dermatitis. Food Agric Immunol 2020; 31(1): 1014–35.
<https://doi.org/10.1080/09540105.2020.1799947>
39. J, Bukač J, Vaňková R, et al. Cluster analysis of molecular components in 100 patients suffering from atopic dermatitis according to the ISAC Multiplex testing. Food Agric Immunol 2020; 31(1): 810–31.
40. J, Bukač J, Vaňková R, Krčmová I, Krejsek J, Andrýs C. Sensitisation to molecular components in patients with atopic dermatitis, relation to asthma bronchiale and allergic rhinitis. Food Agric Immunol 2020; 31(1): 600–29.
<https://doi.org/10.1080/09540105.2020.1747406>
41. Vaňková R, Čelakovská J, Bukač J, Krčmová I, Krejsek J, Andrýs C. Využití multiplexového systému ImmunoCAP ISAC k určení senzibilizace na molekulární komponenty související se závažností atopické dermatitidy. Čes-slov Derm, in print.
42. S, Braun T, Eder K, Berghaus A, Gröger M. Clinical Relevance of IgE to Profilin and/or Polcalcin in Pollen-Sensitized Patients. Int Arch Allergy Immunol 2016; 169: 101–7.
<https://doi.org/10.1159/000444279>
43. R, Villalba M, Batanero E, et al. Allergenic diversity of the olive pollen. Allergy Eur J Allergy Clin Immunol Suppl 2002; 57(71): 6–16.
<https://doi.org/10.1034/j.1398-9995.2002.057s71006.x>
44. O, Villalba M, Quiralte J, Polo F, Rodrı R. 1,3-β-glucanases as candidates in latex–pollen–vegetable food cross-reactivity. Clin Exp Allergy 2005; 35: 345–51.
<https://doi.org/10.1111/j.1365-2222.2004.02186.x>
45. B, Messaoudi K, Jacomet F, et al. An update on molecular cat allergens: Fel d 1 and what else? Chapter 1: Fel d 1, the major cat allergen. Allergy, Asthma Clin Immunol 2018; 14(14): 1–9.
<https://doi.org/10.1186/s13223-018-0239-8>
<PubMed>
46. JR, Fujisawa T, Hage M Van, Hedlin G. Current perspectives Allergy to furry animals: New insights, diagnostic approaches, and challenges. J Allergy Clin Immunol 2015; 135(3): 616–25.
<https://doi.org/10.1016/j.jaci.2014.08.026>
47. SU, Domínguez JS. Clinical impact of molecular diagnosis in dog allergy. Clin Transl Allergy 2014; 4(Suppl 2): P52.
<https://doi.org/10.1186/2045-7022-4-S2-P52>
48. G, Brusca I, Scala E, et al. House dust mite allergy in Italy—Diagnostic and clinical relevance of Der p 23 (and of minor allergens): A real-life, multicenter study. Allergy Eur J Allergy Clin Immunol 2019; 74(9): 1787–9.
<https://doi.org/10.1111/all.13776>
49. D, Perna S, Resch Y, et al. Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life. J Allergy Clin Immunol 2017; 139(2): 541–9.
<https://doi.org/10.1016/j.jaci.2016.08.014>
50. S, Illig T, Baurecht H, et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 2006; 118(1): 214–9.
<https://doi.org/10.1016/j.jaci.2006.05.004>
51. Brito F, Alonso AM, Carnés J, et al. Correlation between Alt a 1 levels and clinical symptoms in Alternaria alternata- monosensitized patients. J Investig Allergol Clin Immunol 2012; 22(3): 154–9.
52. MF, Postigo I, Tomaz CT, Martínez J. Alternaria alternata allergens: Markers of exposure, phylogeny and risk of fungi-induced respiratory allergy. Environ Int 2016; 89–90: 71–80.
<https://doi.org/10.1016/j.envint.2016.01.003>
53. LD, Perzanowski MS, Wheatley LM, Platts-Mills TAE, Chapman MD. IgE and IgG antibody responses to recombinant Alt a 1 as a marker of sensitization to Alternaria in asthma and atopic dermatitis. Clin Exp Allergy 2001; 31(12): 1891–5.
<https://doi.org/10.1046/j.1365-2222.2001.00745.x>
54. R, Blaser K. Allergy and immunity to fungal infections and colonization. Eur Respir J 2002; 19(1): 151–7.
<https://doi.org/10.1183/09031936.02.00229102>
55. E, Cecchi L, Guerra C. Molecular Recognition Profiles and Clinical Patterns of PR-10 Sensitization in a Birch-Free Mediterranean Area. Int Arch Allergy Immunol 2017; 173: 138–46.
<https://doi.org/10.1159/000477565>
56. MI, Scaparrotta A, Marcovecchio ML, et al. Usefulness of molecular diagnosis in egg allergic children. Arch Med Sci 2018; 14(1): 132–7.
<https://doi.org/10.5114/aoms.2016.58796>
<PubMed>
57. D, Conte M, Asero R, Re M Da, Stella S. Isolated IgE reactivity to native walnut vicilin-like protein (nJug r 2) on ISACTM microarray is due to cross-reactive carbohydrate epitopes. Clin Chem Lab Med 2013; 51(10): 1991–5.
<https://doi.org/10.1515/cclm-2013-0027>
58. C-J, Lin Y-F, Chiang B-L, Chow L-P. Proteomics and Immunological Analysis of a Novel Shrimp Allergen, Pen m 2. J Immunol 2003; 170(1): 445–53.
<https://doi.org/10.4049/jimmunol.170.1.445>
59. MA, Pascal M, Kharbouchi O El, et al. Shellfish allergens: tropomyosin and beyond. Allergy 2017; 72: 842–8.
<https://doi.org/10.1111/all.13115>
60. AL, Kleine-Tebbe J, Kamath SD. Allergens and molecular diagnostics of shellfish allergy. Allergo J Int 2016; 25(7): 210–8.
<https://doi.org/10.1007/s40629-016-0124-2>
<PubMed>
61. JF, Mccleary N, Nwaru BI, Stoddart A, Sheikh A. Diagnostic accuracy, risk assessment, and cost-effectiveness of component-resolved diagnostics for food allergy: A systematic review. Allergy Eur J Allergy Clin Immunol 2018; 73: 1609–21.
<https://doi.org/10.1111/all.13331>


